NCT06528496 2026-02-10
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
University of Cologne
Samsung Medical Center
Children's Oncology Group
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital